首页 | 本学科首页   官方微博 | 高级检索  
     

肠道菌群对中药糖苷类成分脱糖基代谢的研究进展
引用本文:张圣洁,郭锦瑞,康安,狄留庆. 肠道菌群对中药糖苷类成分脱糖基代谢的研究进展[J]. 中国中药杂志, 2013, 38(10): 1459-1466
作者姓名:张圣洁  郭锦瑞  康安  狄留庆
作者单位:1. 南京中医药大学药学院,江苏南京210023;江苏省中药高效给药系统工程技术研究中心,江苏南京210023;南京市中药微丸产业化工程技术研究中心,江苏南京210023
2. 南京中医药大学药学院,江苏南京,210023
3. 南京中医药大学药学院,江苏南京210023;江苏省中药高效给药系统工程技术研究中心,江苏南京210023;中国药科大学 天然药物活性组分与功效国家重点实验室,江苏南京210009
基金项目:国家自然科学基金项目(81202983,81073071,81273655);天然药物活性组分与功效国家重点实验室(中国药科大学)项目(SKLNMKF201209);南京中医药大学青年自然科学基金项目(11XZR09)
摘    要:中药糖苷类成分是中药中一类重要的活性物质,其药理活性、药代动力学特征及体内存在是目前研究的热点.糖苷类成分在生物体内代谢转化途径主要是由肠道菌群介导的脱糖基代谢,生成苷元后更易吸收入血并发挥药效.该文基于肠道菌群在中药糖苷类成分体内代谢及药效发挥中的重要作用,综述了肠道菌群中代谢中药糖苷类成分的主要糖苷酶,产生糖苷酶的主要菌属,以及代表性糖苷类成分的脱糖基代谢途径.并针对肠道菌群对中药糖苷类成分代谢研究过程中存在的问题进行了初步探讨.

关 键 词:肠道菌群  中药糖苷类成分  脱糖基代谢
收稿时间:2012-12-29

Advance in studies on gut microbiota in de-glycosylation of traditional Chinese medicine glycosides
ZHANG Sheng-jie,GUO Jin-rui,KANG An and DI Liu-qing. Advance in studies on gut microbiota in de-glycosylation of traditional Chinese medicine glycosides[J]. China Journal of Chinese Materia Medica, 2013, 38(10): 1459-1466
Authors:ZHANG Sheng-jie  GUO Jin-rui  KANG An  DI Liu-qing
Affiliation:School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China;Jiangsu Provincial Traditional Chinese Medicine High Efficient Drug Delivery System Engineering Technology Research Center, Nanjing 210023, China;Nanjing Engineering Research Center for Industrialization of Chinese Medicine Pellets, Nanjing 210023, China;School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China;School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China;Jiangsu Provincial Traditional Chinese Medicine High Efficient Drug Delivery System Engineering Technology Research Center, Nanjing 210023, China;State Key Laboratory of Active Component and Efficacy of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China;School of Pharmacy, Nanjing University of Chinese Medicine, Nanjing 210023, China;Jiangsu Provincial Traditional Chinese Medicine High Efficient Drug Delivery System Engineering Technology Research Center, Nanjing 210023, China;Nanjing Engineering Research Center for Industrialization of Chinese Medicine Pellets, Nanjing 210023, China
Abstract:Glycosides are important active components in traditional Chinese medicine (TCM). Their pharmacological activity, pharmacokinetic characteristics and in vivo existence become hotspots of current studies. The metabolic pathways of these glycosides are de-glycosylation mainly mediated by gut microbiota. After glycosides were metabolized into aglycones, they could be absorbed more easily and show better pharmacological effects. In this article, we reviewed the main glycosidase in gut microbiota which helps metabolize TCM glycosides, relevant bacterial strains which generate glycosidase, as well as the de-glycosylated metabolic pathways of the representative glycosides, on the basis of gut microbiota's important roles in in vivo metabolism and efficacy of TCM glycosides. We also preliminarily solved problems in studies on de-glycosylation of TCM glycosides.
Keywords:gut microbiota  traditional Chinese medicines glycoside  de-glycosylation
本文献已被 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号